Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kenneth Olsen

Orthopaedic Surgery Burnsville, MN Medical Doctor

NPI 1528028271 CMS profile 114637

14000 Fairview Dr, Burnsville, MN 55337

Open in the dashboard

General payments

$48,045

100 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kenneth Olsen of Burnsville, MN is reported in the CMS Open Payments database as having received $48,045 across 100 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $750 4
2024 General $10,273 16
2023 General $10,265 32
2022 General $2,506 11
2020 General $7,413 11
2019 General $16,838 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kenneth Olsen
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Kenneth Olsen were reported at $750. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Kenneth Olsen Orthopaedic Surgery median Middle half National median
2019 $16,838 $644 $140–$2,844 $163
2020 $7,413 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $2,506 $598 $128–$2,731 $149
2023 $10,265 $461 $128–$2,264 $160
2024 $10,273 $497 $134–$2,475 $164
2025 $750 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroPort Orthopedics Inc $45,562 84 payments
  2. Zimmer Biomet Holdings, Inc. $1,106 7 payments
  3. Smith+Nephew, Inc. $614 4 payments
  4. MicroPort NaviBot International LLC $262 1 payment
  5. Shalby Advanced Technologies, Inc. $171 1 payment
  6. Avanos Medical $150 1 payment
  7. OrthoSensor Inc. $122 1 payment
  8. Medacta USA, Inc. $59 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33,576 21 payments
  2. Travel and Lodging $8,716 35 payments
  3. Food and Beverage $3,473 42 payments
  4. Consulting Fee $2,279 2 payments
Products named General payments · program years 2019–2025
  1. MPO Hip System Orthopedic Product $25,014 32 payments
  2. MPO Hip System Hip Arthroplasty $16,028 20 payments
  3. MPO Medial Pivot Knee $4,521 32 payments
  4. Navio Surgical System $471 3 payments
  5. Skywalker $262 1 payment
  6. CKS - VitalitE Orthopedics $171 1 payment
  7. Consensus Knee System Orthopedics $171 1 payment
  8. CKS - VitalitE Orthopedics $171 1 payment
  9. CONSENSUS KNEE SYSTEM Orthopedics $171 1 payment
  10. ON-Q* PUMP AND ACCESSORIES $150 1 payment
  11. Other $1,077 11 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

1,026

Median for Orthopedic Surgery: 203

Drug cost

$5,890

Median for Orthopedic Surgery: $1,433

Branded share of claims

5.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ibuprofen Generic 124 $1,890
Oxycodone Hcl Generic 211 $957
Cefadroxil Generic 53 $416
Gabapentin Generic 145 $385
Hydromorphone Hcl Generic 75 $347
Celecoxib Generic 23 $342
Ondansetron Odt Ondansetron Brand 42 $309
Mupirocin Generic 35 $261
Amoxicillin Generic 145 $236
Diclofenac Sodium Generic 15 $199

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$137,114

Of which drugs: $4,267

Medicare patients

267

Average age 73

Services billed

1,194

176 women, 91 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 66%
Depression 25%
Diabetes 19%
Ischemic heart disease 19%
Osteoporosis 19%
Chronic kidney disease 14%
Atrial fibrillation 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 31 124 $572

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

100 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record